Q3 2023 · 13F-HR
PERCEPTIVE ADVISORS LLCholdings as filed
Filed 2023-11-14 · accession 0001012975-23-000471
$3.00B
Reported value
97
Positions
2023-09-30
Period end
Holdings as filed
| CUSIP | Ticker | Issuer | Value | % port. | Shares | Class | Voting |
|---|---|---|---|---|---|---|---|
| 03152W109 | AM6 | AMICUS THERAPEUTICS INC | $336.7M | 11.2% | 27,692,917 | Common | SOLE |
| 15678U128 | CERE1EUR | CEREVEL THERAPEUTICS HLDNG I | $220.2M | 7.35% | 10,088,385 | Common | SOLE |
| 45258J102 | IMVT | IMMUNOVANT INC | $146.4M | 4.88% | 3,814,691 | Common | SOLE |
| 03940C100 | ACLXGBX | ARCELLX INC | $142.3M | 4.75% | 3,965,978 | Common | SOLE |
| 670703107 | NUVL | NUVALENT INC | $113.2M | 3.78% | 2,463,451 | Common | SOLE |
| 834203309 | SLNO | SOLENO THERAPEUTICS INC | $90.7M | 3.03% | 3,074,542 | Common | SOLE |
| 53000N108 | LIANY | LIANBIO | $85.8M | 2.86% | 57,558,451 | Common | SOLE |
| 00973Y108 | AKRO | AKERO THERAPEUTICS INC | $81.9M | 2.73% | 1,619,425 | Common | SOLE |
| 45720L107 | INBXUSD | INHIBRX INC | $78.1M | 2.61% | 4,256,104 | Common | SOLE |
| 01438T106 | ALDX | ALDEYRA THERAPEUTICS INC | $75.8M | 2.53% | 11,350,085 | Common | SOLE |
| 04016X101 | ARGX | ARGENX SE | $74.0M | 2.47% | 150,600 | Common | SOLE |
| 92243G108 | PCVX | VAXCYTE INC | $68.5M | 2.28% | 1,342,751 | Common | SOLE |
| 925050106 | VRNA | VERONA PHARMA PLC | $65.3M | 2.18% | 4,007,197 | Common | SOLE |
| 23257D103 | CBAYUSD | CYMABAY THERAPEUTICS INC | $60.3M | 2.01% | 4,043,191 | Common | SOLE |
| G59665102 | MGTX | MEIRAGTX HLDGS PLC | $55.6M | 1.86% | 11,331,103 | Common | SOLE |
| 462260100 | IOVA | IOVANCE BIOTHERAPEUTICS INC | $54.4M | 1.82% | 11,962,938 | Common | SOLE |
| 55234L105 | LYRAGBP | LYRA THERAPEUTICS INC | $49.9M | 1.66% | 12,757,562 | Common | SOLE |
| 03237H101 | AMLX | AMYLYX PHARMACEUTICALS INC | $49.2M | 1.64% | 2,688,873 | Common | SOLE |
| 10806X102 | BBIO | BRIDGEBIO PHARMA | $46.1M | 1.54% | 1,748,933 | Common | SOLE |
| G5960L103 | MDT | MEDTRONIC PLC | $46.0M | 1.53% | 587,000 | Common | SOLE |
| G76279101 | ROIV | ROIVANT SCIENCES LTD | $44.6M | 1.49% | 3,819,456 | Common | SOLE |
| 254604101 | IRON | DISC MEDICINE INC | $42.1M | 1.40% | 895,641 | Common | SOLE |
| N44445109 | IMTX | IMMATICS N.V | $40.4M | 1.35% | 3,491,500 | Common | SOLE |
| 03770N101 | APGE | APOGEE THERAPEUTICS INC | $38.9M | 1.30% | 1,827,901 | Common | SOLE |
| 22663K107 | CRNX | CRINETICS PHARMACEUTICALS IN | $37.6M | 1.25% | 1,263,732 | Common | SOLE |
| 76155X100 | RVMD | REVOLUTION MEDICINES INC | $36.6M | 1.22% | 1,321,795 | Common | SOLE |
| 85205L107 | SWTXUSD | SPRINGWORKS THERAPEUTICS INC | $35.2M | 1.17% | 1,520,416 | Common | SOLE |
| 05464T104 | AXSM | AXSOME THERAPEUTICS INC | $33.7M | 1.12% | 481,649 | Common | SOLE |
| 413197104 | HRMY | HARMONY BIOSCIENCES HLDGS IN | $32.6M | 1.09% | 996,306 | Common | SOLE |
| 75382E109 | — | RAPT THERAPEUTICS INC | $31.9M | 1.06% | 1,920,658 | Common | SOLE |
| 77313F106 | RCKT | ROCKET PHARMACEUTICALS INC | $31.1M | 1.04% | 1,517,467 | Common | SOLE |
| 63909J108 | NAUT | NAUTILUS BIOTECHNOLOGY INC | $28.8M | 0.96% | 9,111,151 | Common | SOLE |
| 004890109 | ACRV | ACRIVON THERAPEUTICS INC | $28.8M | 0.96% | 3,007,858 | Common | SOLE |
| 87583X109 | TNGX | TANGO THERAPEUTICS INC | $27.2M | 0.91% | 2,418,968 | Common | SOLE |
| 000899104 | ADMA | ADMA BIOLOGICS INC | $25.0M | 0.83% | 6,984,319 | Common | SOLE |
| 89455T109 | TMCI | TREACE MED CONCEPTS INC | $24.0M | 0.80% | 1,834,060 | Common | SOLE |
| 87650L103 | TARS | TARSUS PHARMACEUTICALS INC | $23.0M | 0.77% | 1,296,416 | Common | SOLE |
| 19240Q201 | COGT | COGENT BIOSCIENCES INC | $22.5M | 0.75% | 2,309,470 | Common | SOLE |
| 803607100 | SRPT | SAREPTA THERAPEUTICS INC | $22.1M | 0.74% | 182,720 | Common | SOLE |
| 604749101 | MIRM | MIRUM PHARMACEUTICALS INC | $21.2M | 0.71% | 672,042 | Common | SOLE |
| 68572M106 | OBIO | ORCHESTRA BIOMED HLDGS INC | $21.2M | 0.71% | 2,432,089 | Common | SOLE |
| 98420N105 | XENE | XENON PHARMACEUTICALS INC | $21.1M | 0.70% | 617,500 | Common | SOLE |
| 92511W108 | — | VERRICA PHARMACEUTICALS INC | $19.6M | 0.65% | 5,038,983 | Common | SOLE |
| G1110E107 | BHVN | BIOHAVEN LTD | $19.6M | 0.65% | 751,820 | Common | SOLE |
| 558868105 | MDGL | MADRIGAL PHARMACEUTICALS INC | $18.2M | 0.61% | 124,637 | Common | SOLE |
| 64125C109 | NBIX | NEUROCRINE BIOSCIENCES INC | $17.9M | 0.60% | 159,242 | Common | SOLE |
| 74366E102 | PTGX | PROTAGONIST THERAPEUTICS INC | $17.6M | 0.59% | 1,054,273 | Common | SOLE |
| 75525N107 | — | RAYZEBIO INC | $17.2M | 0.58% | 776,805 | Common | SOLE |
| 12674W109 | CABA | CABALETTA BIO INC | $17.2M | 0.57% | 1,132,491 | Common | SOLE |
| 75943R102 | RLAY | RELAY THERAPEUTICS INC | $16.3M | 0.55% | 1,943,097 | Common | SOLE |
| 04635X102 | CATBUSD | ASTRIA THERAPEUTICS INC | $16.3M | 0.54% | 2,189,462 | Common | SOLE |
| 92790C104 | VRDN | VIRIDIAN THERAPEUTICS INC | $15.5M | 0.52% | 1,011,205 | Common | SOLE |
| 228903100 | AORT | ARTIVION INC | $14.1M | 0.47% | 931,352 | Common | SOLE |
| G31249108 | ESTA | ESTABLISHMENT LABS HLDGS INC | $13.6M | 0.45% | 277,683 | Common | SOLE |
| 30052C107 | EOLS | EVOLUS INC | $13.6M | 0.45% | 1,485,801 | Common | SOLE |
| 87357P100 | TCMD | TACTILE SYS TECHNOLOGY INC | $9.9M | 0.33% | 707,159 | Common | SOLE |
| 09077A106 | BMEA | BIOMEA FUSION | $9.9M | 0.33% | 716,441 | Common | SOLE |
| 04746L104 | — | ATHIRA PHARMA INC | $9.7M | 0.32% | 4,797,278 | Common | SOLE |
| 632307104 | NTRA | NATERA INC | $9.7M | 0.32% | 218,178 | Common | SOLE |
| 98985Y108 | ZYME | ZYMEWORKS INC | $9.2M | 0.31% | 1,446,123 | Common | SOLE |
| 83422E204 | SLDB | SOLID BIOSCIENCES INC | $8.8M | 0.29% | 3,495,933 | Common | SOLE |
| 76243J105 | RYTM | RHYTHM PHARMACEUTICALS INC | $8.7M | 0.29% | 380,828 | Common | SOLE |
| 14171W103 | — | CAREMAX INC | $8.1M | 0.27% | 3,823,557 | Common | SOLE |
| G72800108 | PRTA | PROTHENA CORP PLC | $8.0M | 0.27% | 165,615 | Common | SOLE |
| 690145107 | OMGBP | OUTSET MED INC | $7.2M | 0.24% | 661,977 | Common | SOLE |
| 36118A100 | — | FUSION PHARMACEUTICALS INC | $7.2M | 0.24% | 2,751,395 | Common | SOLE |
| 515069201 | — | LANDOS BIOPHARMA INC | $5.8M | 0.19% | 1,486,991 | Common | SOLE |
| 00973Y108 | AKRO | AKERO THERAPEUTICS INC | $5.5M | 0.18% | 800,000 | CALL | SOLE |
| 880881107 | 430 | TERNS PHARMACEUTICALS INC | $5.4M | 0.18% | 1,075,000 | Common | SOLE |
| 90240B106 | TYRA | TYRA BIOSCIENCES INC | $5.0M | 0.17% | 360,000 | Common | SOLE |
| 63009J107 | NBTX | NANOBIOTIX | $4.9M | 0.16% | 555,066 | Common | SOLE |
| 05463X106 | AXGN | AXOGEN INC | $4.4M | 0.15% | 875,898 | Common | SOLE |
| 29415J106 | — | ENVVENO MEDICAL CORPORATION | $4.2M | 0.14% | 781,615 | Common | SOLE |
| 98420X103 | ASNSUSD | X4 PHARMACEUTICALS INC | $3.9M | 0.13% | 3,545,454 | Common | SOLE |
| 670002401 | NVAX | NOVAVAX INC | $3.8M | 0.13% | 1,300,000 | PUT | SOLE |
| 83444K105 | SLGCUSD | SOMALOGIC INC | $3.6M | 0.12% | 1,500,000 | Common | SOLE |
| 89422G107 | TVTX | TRAVERE THERAPEUTICS INC | $3.6M | 0.12% | 400,000 | Common | SOLE |
| 803607100 | SRPT | SAREPTA THERAPEUTICS INC | $3.1M | 0.10% | 100,000 | CALL | SOLE |
| 730541109 | — | POINT BIOPHARMA GLOBAL INC | $2.6M | 0.09% | 800,000 | PUT | SOLE |
| 03969K108 | ARQT | ARCUTIS BIOTHERAPEUTICS INC | $2.6M | 0.09% | 300,000 | PUT | SOLE |
| 30233G209 | EYPT | EYEPOINT PHARMACEUTICALS INC | $2.5M | 0.08% | 750,000 | PUT | SOLE |
| 50107A104 | KRON1USD | KRONOS BIO INC | $2.3M | 0.08% | 1,752,745 | Common | SOLE |
| 34962G109 | TOCAEUR | FORTE BIOSCIENCES INC | $2.2M | 0.07% | 3,265,359 | Common | SOLE |
| 00445A100 | — | ACELYRIN INC | $2.0M | 0.07% | 200,000 | Common | SOLE |
| 282559103 | ETNBGBP | 89BIO INC | $1.6M | 0.05% | 400,000 | CALL | SOLE |
| 00461U105 | ACRS | ACLARIS THERAPEUTICS INC | $1.4M | 0.05% | 500,000 | PUT | SOLE |
| 00773J202 | SYRE | AEGLEA BIOTHERAPEUTICS INC | $993,671 | 0.03% | 81,116 | Common | SOLE |
| 91822J202 | LO9A | VBI VACCINES INC CDA | $925,507 | 0.03% | 1,381,355 | Common | SOLE |
| 82933R100 | — | SINGULAR GENOMICS SYSTEMS IN | $900,385 | 0.03% | 2,363,214 | Common | SOLE |
| 92536C103 | VERUEUR | VERU INC | $783,622 | 0.03% | 1,089,878 | Common | SOLE |
| 92686J106 | VKTX | VIKING THERAPEUTICS INC | $240,000 | 0.01% | 300,000 | CALL | SOLE |
| 03753U106 | APLSUSD | APELLIS PHARMACEUTICALS INC | $72,500 | 0.00% | 100,000 | PUT | SOLE |
| 52187K200 | CYPH | LEAP THERAPEUTICS INC | $62,059 | 0.00% | 44,971 | Common | SOLE |
| 62014P405 | — | MOTUS GI HLDGS INC | $40,512 | 0.00% | 90,027 | Common | SOLE |
| 14171W111 | — | CAREMAX INC | $11,250 | 0.00% | 60,000 | Common | SOLE |
| 26886C115 | — | EQRX INC | $10,000 | 0.00% | 250,000 | Common | SOLE |
| 86889P117 | SRZNW | SURROZEN INC | $6,667 | 0.00% | 166,666 | Common | SOLE |
Source: SEC EDGAR · raw 13F holdings as filed. The Class column shows the option type when reported (Put/Call) or Common when the issuer's equity is held directly. 13F discloses long positions only.